Siglec-6 is expressed in gestational trophoblastic disease and affects proliferation, apoptosis and invasion
Open Access
- 22 October 2012
- journal article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 19 (6), 827-840
- https://doi.org/10.1530/erc-11-0379
Abstract
Sialic acid immunoglobulin-like lectin (Siglec)-6 is a transmembrane receptor that binds leptin. Leptin is an obesity-associated peptide hormone overexpressed in gestational trophoblastic disease (GTD). GTD encompasses several placental abnormalities that range from benign to malignant. Among GTD, molar placentas are characterized by excess proliferation, whereas gestational trophoblastic neoplasias (GTN) have characteristically aggressive invasion. We hypothesized that in GTD, Siglec-6 expression would increase with disease severity and that Siglec-6 and leptin would promote proliferation, inhibit apoptosis and/or promote invasion. Siglec-6 expression patterns were evaluated with particular attention to the diagnostic utility of Siglec-6 in GTD (controls: normal placentas (n=32), hydropic abortus placentas (n=7), non-GTD reproductive tract cancers (n=2); GTD: partial moles (PM; n=11), complete moles (n=24), GTN (n=6)). In normal placentas, Siglec-6 expression dramatically decreased after 8 weeks gestation. Complete molar placentas had significantly higher Siglec-6 expression than controls, but expression was not significantly different from PM. In GTN, Siglec-6 expression was low. These data suggest that Siglec-6 may have diagnostic utility for distinguishing complete moles from normal and hydropic abortus placentas. Functional studies in choriocarcinoma-derived BeWO cells demonstrated a complex interplay between Siglec-6 expression and leptin exposure. In cells lacking Siglec-6, leptin treatment promoted invasion, likely through interaction with LepR leptin receptor, without affecting proliferation or apoptosis. Siglec-6 expression promoted proliferation in a leptin-dependent manner, but protected cells from apoptosis and promoted invasion in a leptin-independent manner. We propose that Siglec-6 and leptin play a role in the aberrant properties characteristic of GTD, namely excess proliferation and invasion.Keywords
This publication has 38 references indexed in Scilit:
- Glycodelin-A Protein Interacts with Siglec-6 Protein to Suppress Trophoblast Invasiveness by Down-regulating Extracellular Signal-regulated Kinase (ERK)/c-Jun Signaling PathwayJournal of Biological Chemistry, 2011
- Severe Preeclampsia-Related Changes in Gene Expression at the Maternal-Fetal Interface Include Sialic Acid-Binding Immunoglobulin-Like Lectin-6 and Pappalysin-2Endocrinology, 2008
- Directional secretion and transport of leptin and expression of leptin receptor isoforms in human placental BeWo cellsMolecular and Cellular Endocrinology, 2005
- The transcriptional repressor Snail promotes mammary tumor recurrenceCancer Cell, 2005
- Improving the Accuracy of Fetal Foot Length to Confirm Gestational DurationObstetrics & Gynecology, 2005
- Expression of leptin and leptin receptors in gestational trophoblastic diseasesGynecologic Oncology, 2004
- Trophoblastic diseaseInternational Journal of Clinical Oncology, 2000
- OB-BP1/Siglec-6Published by Elsevier BV ,1999
- Human leptin characterizationNature, 1996
- The problem of identification of prognostic factors for persistent trophoblastic diseaseGynecologic Oncology, 1988